Research.Patient.info

Acutely Psychotic Patients with Schizophrenia research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingPhase II and Phase III (Integrated)
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Patients with Schizophrenia, Followed by an Open-label Extension Phase
Romania